{
  "id": 16116,
  "date": "2020-02-14T14:21:13",
  "date_gmt": "2020-02-14T14:21:13",
  "guid": { "rendered": "./?p=16116" },
  "modified": "2020-12-17T15:30:59",
  "modified_gmt": "2020-12-17T15:30:59",
  "slug": "nitrosamines-ema-nationalauthorities-regulatory-2",
  "status": "publish",
  "type": "post",
  "link": "./nitrosamines/ema/nationalauthorities/regulatory",
  "title": {
    "rendered": "Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities"
  },
  "content": {
    "rendered": "<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-first\" style=\"width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_3_4 3_4 fusion-three-fourth fusion-column-first\" style=\"width:75%;width:calc(75% - ( ( 4% ) * 0.75 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\"><h1>Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities</h1>\n</div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_4 1_4 fusion-one-fourth fusion-column-last\" style=\"width:25%;width:calc(25% - ( ( 4% ) * 0.25 ) );margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><img width=\"293\" height=\"300\" title=\"800px-Nitrosamine_Formulae_V.1.svg\" src=\"./wp-content/uploads/2020/02/800px-Nitrosamine_Formulae_V.1.svg-293x300.png\" class=\"img-responsive wp-image-16118\"/></span><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-first\" style=\"width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-last\" style=\"width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-4 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-2\"><p>The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. MAHs are obliged to submit the conclusions of risk evaluations for all of their medicinal products containing chemically synthesized API by 26.03.2020.</p>\n</div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-text fusion-text-3\"><p>Kinapse can provide support for each step of the process, including:</p>\n<p><ul class=\"fusion-checklist fusion-checklist-1\" style=\"font-size:14px;line-height:23.8px;\"><li class=\"fusion-li-item\"><span style=\"height:23.8px;width:23.8px;margin-right:9.8px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-search fas\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:33.6px;\">Interpretation of the notification and how it is applicable to you</div></li></ul>\n<ul class=\"fusion-checklist fusion-checklist-2\" style=\"font-size:14px;line-height:23.8px;\"><li class=\"fusion-li-item\"><span style=\"height:23.8px;width:23.8px;margin-right:9.8px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-search fas\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:33.6px;\">Developing a template for conducting nitrosamine risk assessments</div></li></ul>\n<ul class=\"fusion-checklist fusion-checklist-3\" style=\"font-size:14px;line-height:23.8px;\"><li class=\"fusion-li-item\"><span style=\"height:23.8px;width:23.8px;margin-right:9.8px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-search fas\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:33.6px;\">Advise you regarding risk evaluation and mitigation</div></li></ul>\n<ul class=\"fusion-checklist fusion-checklist-4\" style=\"font-size:14px;line-height:23.8px;\"><li class=\"fusion-li-item\"><span style=\"height:23.8px;width:23.8px;margin-right:9.8px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-search fas\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:33.6px;\">Support collation of all assessment information and submission of necessary templates to the EMA and/or national authorities.</div></li></ul></p>\n<p><span style=\"color: #1d8674;\">Use the button below to download the PDF and learn more.</span></p>\n</div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#e0dede;border-top-width:1px;\"></div></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-aligncenter\"><style type=\"text/css\">.fusion-button.button-1 .fusion-button-text, .fusion-button.button-1 i {color:#ffffff;}.fusion-button.button-1 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1:hover .fusion-button-text, .fusion-button.button-1:hover i,.fusion-button.button-1:focus .fusion-button-text, .fusion-button.button-1:focus i,.fusion-button.button-1:active .fusion-button-text, .fusion-button.button-1:active{color:#ffffff;}.fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1:hover, .fusion-button.button-1:focus, .fusion-button.button-1:active{border-color:#ffffff;}.fusion-button.button-1 {border-color:#ffffff;border-radius:0px;}.fusion-button.button-1{background: teal;}.fusion-button.button-1:hover,.button-1:focus,.fusion-button.button-1:active{background: #1d866c;}</style><a class=\"fusion-button button-flat fusion-button-default-size button-custom button-1 fusion-button-default-span fusion-button-default-type\" target=\"_self\" href=\"https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-information-nitrosamines-marketing-authorisation-holders_en.pdf\"><span class=\"fusion-button-text\">DOWNLOAD THE GUIDELINE</span></a></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#e0dede;border-top-width:1px;\"></div></div><div class=\"fusion-sep-clear\"></div><ul class=\"fusion-checklist fusion-checklist-5\" style=\"font-size:13px;line-height:22.1px;\"><li class=\"fusion-li-item\"><span style=\"height:22.1px;width:22.1px;margin-right:9.1px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa fa-arrow-left\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:31.2px;\">\n<p><a href=\"./blog/\">Back to Kinapse blog</a></p>\n</div></li></ul><div class=\"fusion-clearfix\"></div></div></div></div></div></p>\n",
    "protected": false
  },
  "excerpt": { "rendered": "", "protected": false },
  "author": 16,
  "featured_media": 16117,
  "comment_status": "open",
  "ping_status": "open",
  "sticky": false,
  "template": "",
  "format": "standard",
  "meta": { "_mi_skip_tracking": false },
  "categories": [35],
  "tags": [],
  "acf": [],
  "yoast_head": "<!-- This site is optimized with the Yoast SEO plugin v19.9 - https://yoast.com/wordpress/plugins/seo/ -->\n<title>Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities</title>\n<meta name=\"description\" content=\"The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.\" />\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" />\n<link rel=\"canonical\" href=\"./nitrosamines/ema/nationalauthorities/regulatory/\" />\n<meta property=\"og:locale\" content=\"en_GB\" />\n<meta property=\"og:type\" content=\"article\" />\n<meta property=\"og:title\" content=\"Kinapse welcomes you to ICH Q12\" />\n<meta property=\"og:description\" content=\"The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.\" />\n<meta property=\"og:url\" content=\"./nitrosamines/ema/nationalauthorities/regulatory/\" />\n<meta property=\"og:site_name\" content=\"Kinapse website\" />\n<meta property=\"article:published_time\" content=\"2020-02-14T14:21:13+00:00\" />\n<meta property=\"article:modified_time\" content=\"2020-12-17T15:30:59+00:00\" />\n<meta property=\"og:image\" content=\"./wp-content/uploads/2015/12/Webinar-Achieving-EMA-policy-0070-compliance.jpg\" />\n\t<meta property=\"og:image:width\" content=\"1200\" />\n\t<meta property=\"og:image:height\" content=\"468\" />\n\t<meta property=\"og:image:type\" content=\"image/jpeg\" />\n<meta name=\"author\" content=\"Konstantina Konstantinopoulou\" />\n<meta name=\"twitter:card\" content=\"summary_large_image\" />\n<meta name=\"twitter:title\" content=\"Kinapse welcomes you to ICH Q12\" />\n<meta name=\"twitter:image\" content=\"./wp-content/uploads/2015/12/Webinar-Achieving-EMA-policy-0070-compliance.jpg\" />\n<meta name=\"twitter:label1\" content=\"Written by\" />\n\t<meta name=\"twitter:data1\" content=\"Konstantina Konstantinopoulou\" />\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" />\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" />\n<script type=\"application/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"./nitrosamines/ema/nationalauthorities/regulatory/\",\"url\":\"./nitrosamines/ema/nationalauthorities/regulatory/\",\"name\":\"Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities\",\"isPartOf\":{\"@id\":\"./#website\"},\"datePublished\":\"2020-02-14T14:21:13+00:00\",\"dateModified\":\"2020-12-17T15:30:59+00:00\",\"author\":{\"@id\":\"./#/schema/person/e5ad1bfc52f97a0dd21ea22bd11f8533\"},\"description\":\"The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.\",\"breadcrumb\":{\"@id\":\"./nitrosamines/ema/nationalauthorities/regulatory/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"./nitrosamines/ema/nationalauthorities/regulatory/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"./nitrosamines/ema/nationalauthorities/regulatory/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"./\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities\"}]},{\"@type\":\"WebSite\",\"@id\":\"./#website\",\"url\":\"./\",\"name\":\"Kinapse website\",\"description\":\"Kinapse website\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"./?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"./#/schema/person/e5ad1bfc52f97a0dd21ea22bd11f8533\",\"name\":\"Konstantina Konstantinopoulou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"./#/schema/person/image/\",\"url\":\"https://secure.gravatar.com/avatar/31df1069f4b65fe2cb70fc4a99a52f98?s=96&d=mm&r=g\",\"contentUrl\":\"https://secure.gravatar.com/avatar/31df1069f4b65fe2cb70fc4a99a52f98?s=96&d=mm&r=g\",\"caption\":\"Konstantina Konstantinopoulou\"},\"url\":\"./author/konstantina-konstantinopoulou/\"}]}</script>\n<!-- / Yoast SEO plugin. -->",
  "yoast_head_json": {
    "title": "Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities",
    "description": "The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.",
    "robots": {
      "index": "index",
      "follow": "follow",
      "max-snippet": "max-snippet:-1",
      "max-image-preview": "max-image-preview:large",
      "max-video-preview": "max-video-preview:-1"
    },
    "canonical": "./nitrosamines/ema/nationalauthorities/regulatory/",
    "og_locale": "en_GB",
    "og_type": "article",
    "og_title": "Kinapse welcomes you to ICH Q12",
    "og_description": "The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.",
    "og_url": "./nitrosamines/ema/nationalauthorities/regulatory/",
    "og_site_name": "Kinapse website",
    "article_published_time": "2020-02-14T14:21:13+00:00",
    "article_modified_time": "2020-12-17T15:30:59+00:00",
    "og_image": [
      {
        "width": 1200,
        "height": 468,
        "url": "./wp-content/uploads/2015/12/Webinar-Achieving-EMA-policy-0070-compliance.jpg",
        "type": "image/jpeg"
      }
    ],
    "author": "Konstantina Konstantinopoulou",
    "twitter_card": "summary_large_image",
    "twitter_title": "Kinapse welcomes you to ICH Q12",
    "twitter_image": "./wp-content/uploads/2015/12/Webinar-Achieving-EMA-policy-0070-compliance.jpg",
    "twitter_misc": {
      "Written by": "Konstantina Konstantinopoulou",
      "Estimated reading time": "12 minutes"
    },
    "schema": {
      "@context": "https://schema.org",
      "@graph": [
        {
          "@type": "WebPage",
          "@id": "./nitrosamines/ema/nationalauthorities/regulatory/",
          "url": "./nitrosamines/ema/nationalauthorities/regulatory/",
          "name": "Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities",
          "isPartOf": { "@id": "./#website" },
          "datePublished": "2020-02-14T14:21:13+00:00",
          "dateModified": "2020-12-17T15:30:59+00:00",
          "author": {
            "@id": "./#/schema/person/e5ad1bfc52f97a0dd21ea22bd11f8533"
          },
          "description": "The deadline to respond to EMA Art. 5(3) Referral on NITROSAMINES is fast approaching. Kinapse can provide support for each step of the process.",
          "breadcrumb": {
            "@id": "./nitrosamines/ema/nationalauthorities/regulatory/#breadcrumb"
          },
          "inLanguage": "en-GB",
          "potentialAction": [
            {
              "@type": "ReadAction",
              "target": [
                "./nitrosamines/ema/nationalauthorities/regulatory/"
              ]
            }
          ]
        },
        {
          "@type": "BreadcrumbList",
          "@id": "./nitrosamines/ema/nationalauthorities/regulatory/#breadcrumb",
          "itemListElement": [
            {
              "@type": "ListItem",
              "position": 1,
              "name": "Home",
              "item": "./"
            },
            {
              "@type": "ListItem",
              "position": 2,
              "name": "Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities"
            }
          ]
        },
        {
          "@type": "WebSite",
          "@id": "./#website",
          "url": "./",
          "name": "Kinapse website",
          "description": "Kinapse website",
          "potentialAction": [
            {
              "@type": "SearchAction",
              "target": {
                "@type": "EntryPoint",
                "urlTemplate": "./?s={search_term_string}"
              },
              "query-input": "required name=search_term_string"
            }
          ],
          "inLanguage": "en-GB"
        },
        {
          "@type": "Person",
          "@id": "./#/schema/person/e5ad1bfc52f97a0dd21ea22bd11f8533",
          "name": "Konstantina Konstantinopoulou",
          "image": {
            "@type": "ImageObject",
            "inLanguage": "en-GB",
            "@id": "./#/schema/person/image/",
            "url": "https://secure.gravatar.com/avatar/31df1069f4b65fe2cb70fc4a99a52f98?s=96&d=mm&r=g",
            "contentUrl": "https://secure.gravatar.com/avatar/31df1069f4b65fe2cb70fc4a99a52f98?s=96&d=mm&r=g",
            "caption": "Konstantina Konstantinopoulou"
          },
          "url": "./author/konstantina-konstantinopoulou/"
        }
      ]
    }
  },
  "_links": {
    "self": [{ "href": "./wp-json/wp/v2/posts/16116" }],
    "collection": [{ "href": "./wp-json/wp/v2/posts" }],
    "about": [{ "href": "./wp-json/wp/v2/types/post" }],
    "author": [
      { "embeddable": true, "href": "./wp-json/wp/v2/users/16" }
    ],
    "replies": [
      {
        "embeddable": true,
        "href": "./wp-json/wp/v2/comments?post=16116"
      }
    ],
    "version-history": [
      { "count": 24, "href": "./wp-json/wp/v2/posts/16116/revisions" }
    ],
    "predecessor-version": [
      {
        "id": 16880,
        "href": "./wp-json/wp/v2/posts/16116/revisions/16880"
      }
    ],
    "wp:featuredmedia": [
      { "embeddable": true, "href": "./wp-json/wp/v2/media/16117" }
    ],
    "wp:attachment": [{ "href": "./wp-json/wp/v2/media?parent=16116" }],
    "wp:term": [
      {
        "taxonomy": "category",
        "embeddable": true,
        "href": "./wp-json/wp/v2/categories?post=16116"
      },
      {
        "taxonomy": "post_tag",
        "embeddable": true,
        "href": "./wp-json/wp/v2/tags?post=16116"
      }
    ],
    "curies": [
      { "name": "wp", "href": "https://api.w.org/{rel}", "templated": true }
    ]
  }
}
